<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03357146</url>
  </required_header>
  <id_info>
    <org_study_id>RAO-OCTA-1253</org_study_id>
    <nct_id>NCT03357146</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion</brief_title>
  <acronym>RAO-OCTA</acronym>
  <official_title>Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery&#xD;
      occlusion with non-invasive, non-contact optical coherence tomography angiography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Occlusion of the retinal arteries is an emergency which causes sudden, painless unilateral&#xD;
      vision loss. Loss of blood flow causes ischemic damage to the retina. The extent of damage&#xD;
      depends on the area affected.&#xD;
&#xD;
      Following the acute phase of the disease re-canalization occurs and lesser blood flow can be&#xD;
      detected usually without functional recovery.&#xD;
&#xD;
      Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery&#xD;
      occlusion.&#xD;
&#xD;
      Standard procedures to examine this disease include retinoscopy following pupil dilation,&#xD;
      fluorescein angiography and more recently, optical coherence tomography (OCT).&#xD;
&#xD;
      The latest direction in OCT development was OCT angiography (OCTA) which is a software&#xD;
      upgrade that allows detection of blood flow based on motion contrast. Similar to previous OCT&#xD;
      machines OCTA is also non-invasive and non-contact and does not require any intravenous&#xD;
      agents.&#xD;
&#xD;
      OCT machines are approved in the EU and the US and are not experimental devices.&#xD;
&#xD;
      The device used in this study is the commercially available Zeiss Cirrus HD OCT Angioplex&#xD;
      5000 that operates with spectral-domain technology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Actual">August 30, 2021</completion_date>
  <primary_completion_date type="Actual">August 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Capillary density in relation to healthy subjects</measure>
    <time_frame>Through study completion, 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of capillary density and retinal thickness</measure>
    <time_frame>Through study completion, 1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Retinal Artery Occlusion</condition>
  <arm_group>
    <arm_group_label>CRA</arm_group_label>
    <description>Patients with chronic retinal artery occlusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical coherence tomography angiography</intervention_name>
    <description>OCTA scans per built-in device protocol</description>
    <arm_group_label>CRA</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        White caucasias&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  central or branch retinal artery occlusion&#xD;
&#xD;
          -  at least 6 months of onset&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  known epilepsy&#xD;
&#xD;
          -  incapacity&#xD;
&#xD;
          -  presence of optical media opacities that would disturb the imaging&#xD;
&#xD;
          -  presence of other retinal diseases that would disturb the evaluation of images&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miklos Schneider</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University, Department of Ophthalmology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Semmelweis University, Department of Ophthalmology</name>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Bonini Filho MA, Adhi M, de Carlo TE, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Kuehlewein L, Sadda SR, Sarraf D, Duker JS, Waheed NK. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN RETINAL ARTERY OCCLUSION. Retina. 2015 Nov;35(11):2339-46. doi: 10.1097/IAE.0000000000000850.</citation>
    <PMID>26457398</PMID>
  </reference>
  <reference>
    <citation>Chalam KV, Sambhav K. Optical Coherence Tomography Angiography in Retinal Diseases. J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):84-92. doi: 10.4103/2008-322X.180709. Review.</citation>
    <PMID>27195091</PMID>
  </reference>
  <reference>
    <citation>Jia Y, Bailey ST, Hwang TS, McClintic SM, Gao SS, Pennesi ME, Flaxel CJ, Lauer AK, Wilson DJ, Hornegger J, Fujimoto JG, Huang D. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2395-402. doi: 10.1073/pnas.1500185112. Epub 2015 Apr 20.</citation>
    <PMID>25897021</PMID>
  </reference>
  <reference>
    <citation>Samara WA, Say EA, Khoo CT, Higgins TP, Magrath G, Ferenczy S, Shields CL. CORRELATION OF FOVEAL AVASCULAR ZONE SIZE WITH FOVEAL MORPHOLOGY IN NORMAL EYES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2015 Nov;35(11):2188-95. doi: 10.1097/IAE.0000000000000847.</citation>
    <PMID>26469536</PMID>
  </reference>
  <reference>
    <citation>Savastano MC, Lumbroso B, Rispoli M. IN VIVO CHARACTERIZATION OF RETINAL VASCULARIZATION MORPHOLOGY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2015 Nov;35(11):2196-203. doi: 10.1097/IAE.0000000000000635.</citation>
    <PMID>25932558</PMID>
  </reference>
  <reference>
    <citation>Spaide RF. VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY. Retina. 2015 Nov;35(11):2181-7. doi: 10.1097/IAE.0000000000000764.</citation>
    <PMID>26428608</PMID>
  </reference>
  <reference>
    <citation>Yu S, Lu J, Cao D, Liu R, Liu B, Li T, Luo Y, Lu L. The role of optical coherence tomography angiography in fundus vascular abnormalities. BMC Ophthalmol. 2016 Jul 13;16:107. doi: 10.1186/s12886-016-0277-2.</citation>
    <PMID>27412442</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 23, 2017</study_first_submitted>
  <study_first_submitted_qc>November 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Miklos Schneider MD, PhD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Artery Occlusion</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

